Skip to main content

Table 3 Willingness to start preventive medication

From: Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis

Disease risk At risk of RA (%) At risk of axSpA (%) Rheumatologists (%) At risk of RA versus at risk of axSpA At risk of RA versus rheumatologists
  100% effective medication, no side effects
30% 53 55 74 p = 0.812 p = 0.017
70% 69 92 92 p = 0.005 p = 0.002
  100% effective medication, minor side effects of immune suppression
30% 26 29 31 p = 0.727 p = 0.554
70% 40 66 76 p = 0.007 p < 0.001
  100% effective medication, minor general side effects
30% 40 47 88 p = 0.433 p < 0.001
  Medication postpones disease development for 10 years, no side effects
70% 61 66 57 p = 0.604 p = 0.652
  1. axSpA axial spondyloarthritis, RA rheumatoid arthritis